Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study.
Sean D SullivanTimothy S BaileyRonan RousselFang Liz ZhouZsolt BosnyakRonald PreblickJukka WesterbackaRishab A GuptaLawrence BlondePublished in: Diabetes, obesity & metabolism (2018)
In a real-world setting, switching from Gla-100 or IDet to Gla-300 or IDeg was associated with similar improvements in glycaemic control and hypoglycaemia in adult patients with T2D.